Noel Genomics
  • Therapeutic Area
    • Multiple Myeloma
    • Diffuse Large B-Cell Lymphoma
    • Large B-Cell Lymphoma
    • Mantle Cell Lymphoma
    • B-Cell Precursor ALL
    • Metastatic Castration-Resistant Prostate Cancer
    • Deep Partial-Thickness Burns
    • Retinal Dystrophy
    • Spinal Muscular Atrophy
  • Company / Innovator
    • Bristol Myers Squibb
    • Gilead Sciences
    • Novartis International
    • Dendreon Corporation
    • Stratatech Corporation
    • Enzyvant Therapeutics
  • News & Updates

Reach us
nhs@noelgenomics.com

Noel Genomics
  • Therapeutic Area
    • Multiple Myeloma
    • Diffuse Large B-Cell Lymphoma
    • Large B-Cell Lymphoma
    • Mantle Cell Lymphoma
    • B-Cell Precursor ALL
    • Metastatic Castration-Resistant Prostate Cancer
    • Deep Partial-Thickness Burns
    • Retinal Dystrophy
    • Spinal Muscular Atrophy
  • Company / Innovator
    • Bristol Myers Squibb
    • Gilead Sciences
    • Novartis International
    • Dendreon Corporation
    • Stratatech Corporation
    • Enzyvant Therapeutics
  • News & Updates
nhs@noelgenomics.com

Browsing Tag

Diffuse Large B-Cell Lymphoma

2 posts

BREYANZI (lisocabtagene maraleucel) – CAR T Cell Therapy by Bristol Myers Squibb (BMS)

Read More
0 Shares
0
0
0

KYMRIAH (tisagenlecleucel) – CAR T Cell Therapy by Novartis Pharmaceuticals

Read More
0 Shares
0
0
0
  • Therapeutic Area
  • Company / Innovator
  • News & Updates
Facebook Twitter Linkedin

 All the information and updates compiled based on the officially published content for the benifit of patients and health care providers. Copyrights for any product or brand mentioned or referred to belong to the respective innovators and licensed companies. Factual information shared for general awareness purpose only. No copyright infringement intended in any manner.

© 2021 – 2022 Noel Health. All Rights Reserved

Back to top